Profiles

Keywords
Last Name
Institution

Aimee C Hodowanec

Title
InstitutionRush University, Rush Medical College
DepartmentInternal Medicine, Division of Cardiology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Buckley LA, Bebenek I, Cornwell PD, Hodowanec A, Jensen EC, Murphy C, Ghantous HN. Drug Development 101: A Primer. Int J Toxicol. 2020 Aug 07; 1091581820939083. PMID: 32762387.
      View in: PubMed
    2. Hodowanec AC, Pikis A, Singer ME. The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective. J Infect Dis. 2020 Mar 05; 221(Supplement_1):S109-S112. PMID: 32134476.
      View in: PubMed
    3. Komatsu TE, Hodowanec AC, Colberg-Poley AM, Pikis A, Singer ME, O'Rear JJ, Donaldson EF. In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products. Antiviral Res. 2019 09; 169:104549. PMID: 31279814.
      View in: PubMed
    4. Hodowanec AC, Lurain NS, Krishnan S, Bosch RJ, Landay AL. Increased CMV IgG Antibody Titer is Associated with Non-AIDS Events among Virologically Suppressed HIV-Positive Persons. Pathog Immun. 2019; 4(1):66-78. PMID: 30815626.
      View in: PubMed
    5. Hodowanec AC, Pikis A, Komatsu TE, Sampson MR, Younis IR, O'Rear JJ, Singer ME. Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives. J Clin Pharmacol. 2019 06; 59(6):784-798. PMID: 30586161.
      View in: PubMed
    6. Fayek SA, Beshears E, Lieber R, Alvey N, Sauer A, Poirier J, Hollinger EF, Olaitan OK, Jensik S, Geyston J, Brokhof MM, Hodowanec AC, Hertl M, Simon DM. Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease. Transplant Proc. 2016 Jul-Aug; 48(6):2056-2064.e1. PMID: 27569944.
      View in: PubMed
    7. Hodowanec A, Williams B, Hanson B, Livak B, Keating S, Lurain N, Adeyemi OM. Soluble CD163 But Not Soluble CD14 Is Associated With Cytomegalovirus Immunoglobulin G Antibody Levels in Virologically Suppressed HIV+ Individuals. J Acquir Immune Defic Syndr. 2015 Dec 15; 70(5):e171-4. PMID: 26569178.
      View in: PubMed
    8. Claus JA, Hodowanec AC, Singh K. Poor positive predictive value of influenza-like illness criteria in adult transplant patients: a case for multiplex respiratory virus PCR testing. Clin Transplant. 2015 Oct; 29(10):938-43. PMID: 26338182.
      View in: PubMed
    9. Hodowanec AC, Simon DM. BK virus screening and management practices among US renal transplant programs: a survey. Transpl Int. 2015 Nov; 28(11):1339-41. PMID: 25959495.
      View in: PubMed
    10. Hodowanec AC, Lee RD, Brady KE, Gao W, Kincaid S, Plants J, Bahk M, Mackman N, Landay AL, Huhn GD. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection. BMC Infect Dis. 2015 Apr 17; 15:190. PMID: 25884329.
      View in: PubMed
    11. Patel T, Singh R, Reddy V, Hodowanec A, Singh K. Sepsis, confusion, rash, and pulmonary hemorrhage in a 36-year-old man with lymphoma. J Clin Microbiol. 2015 Feb; 53(2):369; discussion 758. PMID: 25617439.
      View in: PubMed
    12. Hodowanec AC, Brady KE, Gao W, Kincaid SL, Plants J, Bahk M, Landay AL, Huhn GD. Characterization of CD4? T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients. J Acquir Immune Defic Syndr. 2013 Nov 01; 64(3):232-40. PMID: 24131865.
      View in: PubMed
    13. Hodowanec AC, Simon DM. Late primary cytomegalovirus infection presenting with acute inflammatory demyelinating polyneuropathy in a heart transplant recipient: a case report and review of the literature. Transpl Infect Dis. 2012 Oct; 14(5):E116-20. PMID: 22938143.
      View in: PubMed
    14. Hodowanec AC, Han A, Barker DE, Rubinstein PG, Max B. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature. J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec; 11(6):345-7. PMID: 22930795.
      View in: PubMed
    15. Hodowanec A, Nayak S, Charurat M, Vaughan L, Kanno M, Fantry L. Prevalence of asymptomatic bacterial sexually transmitted infections in hospitalized HIV patients in Baltimore City. J Int Assoc Physicians AIDS Care (Chic). 2012 Jan-Feb; 11(1):16-9. PMID: 21876216.
      View in: PubMed
    16. Hodowanec AC, Trenholme GM. When should INH prophylaxis be given to a dialysis patient with a positive tuberculin skin test but with a normal CXR? Semin Dial. 2011 Jul-Aug; 24(4):440-1. PMID: 21801219.
      View in: PubMed
    Hodowanec's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (109) concept(s)
    _
    Co-Authors Expand Description
    See all (4) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department